Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by University of California, San Diego.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
David K. Shellington, MD, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01589172
First received: April 27, 2012
Last updated: May 1, 2012
Last verified: May 2012

April 27, 2012
May 1, 2012
May 2012
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01589172 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
Evaluating the Use of Thromboelastography to Diagnose and Monitor Coagulopathy Associated With Pediatric Traumatic Brain Injury

The investigators will obtain thromboelastography (TEG) on pediatric patients admitted to the Rady Children's Hospital ICU after traumatic brain injury on admission to our ICU and after 24 hours of care. The investigators hypothesize that TEG will identify abnormalities of coagulation that are not identified by traditional coagulation studies, i.e. prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Trauma patients admitted to the Rady Children's Hospital Pediatric Intensivse Care Unit

  • Traumatic Brain Injury
  • Coagulation Disorder
Not Provided
Pediatric Brain Trauma Patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
40
Not Provided
Not Provided

Inclusion Criteria:

  • less than 15 years of age
  • evidence of intracranial bleed on CT scan or GCS <12

Exclusion Criteria:

  • No intracranial hemorrhage or
  • GCS 13 - 15
Both
up to 15 Years
No
United States
 
NCT01589172
120296
No
David K. Shellington, MD, University of California, San Diego
University of California, San Diego
Not Provided
Principal Investigator: David K Shellington, MD University of California, San Diego
University of California, San Diego
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP